A Wealth of Experience

We have collaborated with our clients on projects to research liver disease, liver treatment, and complications and comorbidities of liver disease. Our experience includes:

  • Acute Liver Failure
  • Hepatitis Infection
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
  • Hepatoxicity
  • Liver Steatosis
  • Thrombocytopenia in chronic hepatitis C

Types of Projects

We have implemented studies to help our clients develop strategies in the hepatic market and to develop and gain market access for products to treat liver disease and complications arising from treatment of liver disease.

Recent projects have included:

Our Experts

Sorrel Wolowacz
Head, European Health Economics
Keith Davis
Head, Health Economics
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Josephine Mauskopf
Vice President, Health Economics
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Xiaolei Zhou
Senior Director, Biostatistics

Selected Recent Hepatic Publications